Search the Community
Showing results for tags 'Journal article'.
Found 3 results
Science Daily, 20 May: A groundbreaking study shows that a single injectable dose of inactivated polio vaccine (IPV) along with bivalent oral polio vaccine could protect up to 90 percent of children from polio and strengthen community protection against the disease. The research, published in the latest edition of The Lancet, provides the evidence behind the worldwide switch to a new polio vaccine strategy by demonstrating that new schedules of the injectable vaccine with the bivalent oral vaccine protect kids much faster and is safer than using the oral vaccine alone. Read the full article
We launched a crossword to draw the attention of health care workers to EIW: http://impfbrief.de/index.php?nav=5#id202 crossword (in German): https://www.xwords-generator.de/de/s/emp74 crossword generator: https://www.xwords-generator.de Has anybody else a similar idea? We would like to try more approaches of this kind.
Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly Vaccine, Volume 34, Issue 22, 11 May 2016, Pages 2469-2476 Man-Kit Leung, Joyce H.S. You Stability of live attenuated rotavirus vaccine with selected preservatives and primary containers Vaccine, Volume 34, Issue 22, 11 May 2016, Pages 2483-2489 Manjari Lal, Courtney Jarrahian, Changcheng Zhu, Nancy A. Hosken, Chris L. McClurkan, David M. Koelle, Eugene Saxon, Andrew Roehrig, Darin Zehrung, Dexiang Chen Managing the risks of vaccine hesitancy and refusals The Lancet Infectious Diseases, Volume 16, Issue 5, May 2016, Pages 518-519 Ève Dubé, Noni E MacDonald The Vaccine Handbook: A Practical Guide for Clinicians Vaccine, Volume 34, Issue 20, 29 April 2016, Page 2402 Deborah L. Wexler Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting Vaccine, Volume 34, Issue 19, 27 April 2016, Pages 2197-2206 Sarah M. Bartsch, Peter J. Hotez, Daniel L. Hertenstein, David J. Diemert, Kristina M. Zapf, Maria Elena Bottazzi, Jeffrey M. Bethony, Shawn T. Brown, Bruce Y. Lee Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection Vaccine, In Press, Uncorrected Proof, Available online 26 April 2016 Hana Hakim, Kim J. Allison, Lee-Ann Van de Velde, Li Tang, Yilun Sun, Patricia M. Flynn, Jonathan A. McCullers The 2016 Vaccine Development Pipeline: A special issue from the World Health Organization Product Development for Vaccine Advisory Committee (PDVAC) Vaccine, In Press, Uncorrected Proof, Available online 21 April 2016 Birgitte Giersing, Kayvon Modjarrad, David C. Kaslow, Jean-Marie Okwo-Bele, Vasee Moorthy Open Access Article The cost-effectiveness of pneumococcal vaccination in healthy adults over 50: An exploration of influential factors for Belgium Vaccine, Volume 34, Issue 18, 19 April 2016, Pages 2106-2112 Adriaan Blommaert, Joke Bilcke, Lander Willem, Jan Verhaegen, Herman Goossens, Philippe Beutels A systematic review of human-to-human transmission of measles vaccine virus Vaccine, In Press, Corrected Proof, Available online 12 April 2016 Kathryn P. Greenwood, Radwan Hafiz, Robert S. Ware, Stephen B. Lambert Ebola Vaccine Trials in Africa and Europe NEJM, April 28, 2016 | S.T. Agnandjiand Others In this set of four phase 1 studies, a recombinant vesicular stomatitis virus (rVSV)–based Ebola vaccine induced Ebola virus–specific immune responses and was associated with side effects that included fever and transient arthritis, rash, and VSV viremia.